Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yolla El-Dakdouki"'
Autor:
Jean‐Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El‐Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi‐Rouche, Patricia Martin‐Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean‐Charles Soria, Christophe Massard, Olivier A. Bernard, Peggy Dartigues, Valérie Camara‐Clayette, Vincent Ribrag
Publikováno v:
American Journal of Hematology. 98:645-657
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83c09f85453cac881c334c43ddbe2644
https://doi.org/10.1002/ajh.26835
https://doi.org/10.1002/ajh.26835
Autor:
Jean-Marie, Michot, Cyril, Quivoron, Clémentine, Sarkozy, Alina, Danu, Julien, Lazarovici, Khalil, Saleh, Yolla, El-Dakdouki, Vincent, Goldschmidt, Camille, Bigenwald, Matteo, Dragani, Rastislav, Bahleda, Capucine, Baldini, Julia, Arfi-Rouche, Patricia, Martin-Romano, Lambros, Tselikas, Anas, Gazzah, Antoine, Hollebecque, Ludovic, Lacroix, David, Ghez, Veronique, Vergé, Christophe, Marzac, Sophie, Cotteret, Wassila, Rahali, Jean-Charles, Soria, Christophe, Massard, Olivier A, Bernard, Peggy, Dartigues, Valérie, Camara-Clayette, Vincent, Ribrag
Publikováno v:
American journal of hematology.
Advances in molecular profiling of newly diagnosed diffuse large cell B lymphoma (DLBCL) have recently refine genetic subgroups. Genetic subgroups remain undetermined at the time of relapse or refractory (RR) disease. This study aims to decipher gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa1f2f1bd60bfe09f1265db9440e311b
https://pubmed.ncbi.nlm.nih.gov/36606708
https://pubmed.ncbi.nlm.nih.gov/36606708
Autor:
Christophe Willekens, Romain Desmaris, Peggy Dartigues, Alina Danu, Julien Lazarovici, Christophe Fermé, David Ghez, Nathalie Ibrahim, Yolla El Dakdouki, Julien Rossignol, Pamela Abdayem, Jean M. Michot, Julia Arfi Rouche, Vincent Ribrag
Publikováno v:
European Journal of Haematology. 106:574-583
Objectives To evaluate the efficacy and tolerability of an attenuated immunochemotherapy regimen based on cytarabine, etoposide and dexamethasone plus rituximab (R-mini-CYVE) in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d48ef07cf1dede0215af385c259cc141
https://doi.org/10.1111/ejh.13589
https://doi.org/10.1111/ejh.13589
Autor:
Jean-Marie Michot, Cyril Quivoron, Clémentine Sarkozy, Alina Danu, Julien Lazarovici, Khalil Saleh, Yolla El-Dakdouki, Vincent Goldschmidt, Camille Bigenwald, Matteo Dragani, Rastislav Bahleda, Capucine Baldini, Julia Arfi-Rouche, Patricia Martin-Romano, Lambros Tselikas, Anas Gazzah, Antoine Hollebecque, Ludovic Lacroix, David Ghez, Veronique Vergé, Christophe Marzac, Sophie Cotteret, Wassila Rahali, Jean-Charles Soria, Christophe Massard, Olivier A. Bernard, Peggy Dartigues, Valérie Camara-Clayette, Vincent Ribrag
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71c291d749d32fce7c73d8413df39b78
https://doi.org/10.2139/ssrn.4057122
https://doi.org/10.2139/ssrn.4057122
Autor:
Mathilde Fusellier, Stéphane Champiat, Anne-Laure Voisin, Capucine Baldini, François-Xavier Danlos, Maxime Annereau, Olivier Lambotte, Christine Mateus, Caroline Robert, Aurélien Marabelle, C. Velter, Jean-Marie Michot, Khadija Cherif, Xavier Mariette, Yolla El Dakdouki
Publikováno v:
Annals of the rheumatic diseases. 78(7)
We read with interest the study of Kostine et al describing rheumatic immune-related adverse events (irAE), which occur in 6.6% of patients treated for cancer by anti-programmed death-(ligand) 1 (PDL1).1 These new adverse effects pose significant cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb572d3ed9ab76bdfa73638088a6b8f8
https://pubmed.ncbi.nlm.nih.gov/29934372
https://pubmed.ncbi.nlm.nih.gov/29934372
Autor:
Anas Gazzah, Jean-Yves Scoazec, Sophie Postel-Vinay, Eric Deutsch, Antoine Hollebecque, Yolla El Dakdouki, Christophe Massard, Eric Solary, Ludovic Lacroix, Monica Arnedos, Etienne Rouleau, Jean-Pierre Armand, Loic Verlingue, Stefan Michiels, Fabrice Andre, Andrea Varga, Rastilav Balheda, Jean-Charles Soria, Capucine Baldini, Eric Angevin, Aurélien Marabelle, Thierry de Baere, Jean-Marie Michot, Olivier Mir
Publikováno v:
European journal of cancer (Oxford, England : 1990). 92
Introduction Therapeutic inhibition of the human epidermal receptor 3 (ERBB3, HER3) has been challenged by the low frequency of ERBB3 somatic alterations across cancer types. We have evaluated the clinical utility to use available inhibitors of the H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dcffd5c03c7c6b4e2c0185bcbf8bb5b
https://pubmed.ncbi.nlm.nih.gov/29413684
https://pubmed.ncbi.nlm.nih.gov/29413684
Autor:
Yolla El Dakdouki, Julia Salleron, Yoan Ditchi, Pernelle Lavaud, Marie-Christine Mathieu, Chloé Broudin, Patrick R. Benusiglio, Donia Lejri, Caroline Baynes, Marie Muller, Olivier Caron
Publikováno v:
The Breast Journal
The Breast Journal, 2019, 25 (1), pp.16-19. ⟨10.1111/tbj.13154⟩
The Breast Journal, 2019, 25 (1), pp.16-19. ⟨10.1111/tbj.13154⟩
International audience; BACKGROUND:Invasive lobular carcinoma (ILC) of the breast has epidemiological, molecular and clinical specificities, and should likely be considered a unique entity. As for genetic susceptibility, CDH1 germline mutations predi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf79589336c685e0f3f02dd2c2bbd89
https://pubmed.ncbi.nlm.nih.gov/30414230
https://pubmed.ncbi.nlm.nih.gov/30414230
Autor:
Patricia Kannouche, Nathalie Chaput, Said Aoufouchi, Laetitia Nebot-Bral, Stéphane Champiat, David Brandao, David Malka, Emmanuelle Despras, Olivier Caron, Aurélien Marabelle, Loic Verlingue, Alexandra Leary, Yolla El-Dakdouki, Etienne Rouleau
Publikováno v:
European journal of cancer (Oxford, England : 1990). 84
Immune checkpoint inhibitors have demonstrated unprecedented clinical activity in a wide range of cancers. Significant therapeutic responses have recently been observed in patients presenting mismatch repair-deficient (MMRD) tumours. MMRD cancers exh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f69dfc275cd33e1e5773525884cb272
https://pubmed.ncbi.nlm.nih.gov/28846956
https://pubmed.ncbi.nlm.nih.gov/28846956
Autor:
Adrien Allorant, Lambros Tselikas, Loic Verlingue, Yolla El Dakdouki, Christophe Massard, Cécile Jovelet, Stefan Michiels, Thierry Debaere, Fabrice Andre, Jean-Charles Soria, A. Hollebecque, Ludovic Lacroix, Gilles Vassal, Etienne Rouleau, Nathalie Auger
Publikováno v:
Cancer Research. 78:2953-2953
Background: MOSCATO 01 (NCT01566019) is a non-randomized single institution prospective clinical trial evaluating clinical benefit of integrating comprehensive molecular profiling into clinical practice to guide treatment in advanced cancers relapsin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5385290cd3697466428ce9d8ce0d1f70
https://doi.org/10.1158/1538-7445.am2018-2953
https://doi.org/10.1158/1538-7445.am2018-2953
Autor:
Andreea Varga, Jessica Menis, Jean-Marie Michot, Aurélien Marabelle, Yolla El-Dakdouki, Xavier Paoletti, Christophe Massard, Anas Gazzah, David Planchard, Saloomeh Rafie, Patricia Martin-Romano, Benjamin Besse, Vincent Ribrag, Capucine Baldini, Antoine Hollebecque, Rastislav Bahleda, Stéphane Champiat, Jean-Charles Soria
Publikováno v:
Cancer Research. 78:CT141-CT141
Background: Antiangiogenic drugs can synergize with immunotherapy in preclinical models. However some molecules have shown unacceptable levels of toxicity when combined with anti-PD-1. We aimed to determine the safety and activity of the nintedanib+p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::310285bcae7d61e8839afc0efd4e5e28
https://doi.org/10.1158/1538-7445.am2018-ct141
https://doi.org/10.1158/1538-7445.am2018-ct141